Commentary|Articles|August 9, 2023
Importance of DCTs Moving Forward
Perceived barriers of DCTs can be quickly overcome to ensure their viability in clinical research.
Advertisement
In this interview from DIA 2023, Janice Chang, CEO of TransCelerate BioPharma, discusses the unique opportuntities presented by decentralized clinical trials (DCTs).
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
2
Is Artificial Intelligence Coming for Clinical Research?
3
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
4
ACT Brief: AI in Clinical Research, FDA Gene Therapy Approval, and High-Performing Hospital Partnerships
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
